Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

3 terminated/withdrawn out of 12 trials

Success Rate

62.5%

-24.0% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 recruiting2 with results

Enrollment Performance

Analytics

N/A
9(100.0%)
9Total
N/A(9)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)